Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/32619
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorKowalski, Sergio Candido-
dc.contributor.authorMorgan, Rebecca L.-
dc.contributor.authorFalavigna, Maicon-
dc.contributor.authorFlórez Gómez, Iván Darío-
dc.contributor.authorEtxeandia Ikobaltzeta, Itziar-
dc.contributor.authorWiercioch, Wojtek-
dc.contributor.authorZhang, Ray Yuan-
dc.contributor.authorSakhia, Faria-
dc.contributor.authorIvanova, Liudmila-
dc.contributor.authorSantesso, Nancy-
dc.contributor.authorSchünemann, Holger Jens-
dc.date.accessioned2022-12-06T20:56:41Z-
dc.date.available2022-12-06T20:56:41Z-
dc.date.issued2018-
dc.identifier.issn1478-4505-
dc.identifier.urihttps://hdl.handle.net/10495/32619-
dc.description.abstractABSTRACT: Background: Guidelines in the healthcare field generally should contain evidence-based recommendations to inform healthcare decisions. Guidelines often require 2 years or more to develop, but certain circumstances necessitate the development of rapid guidelines (RGs) in a short period of time. Upholding methodological rigor while meeting the reduced development timeframe presents a challenge for developing RGs. Our objective was to review current practices and standards for the development of RGs. This is the first of a series of three articles addressing methodological issues around RGs. Methods: We conducted a systematic survey of methods manuals and published RGs to identify reasons for the development of RGs. Data sources included existing guideline manuals, published RGs, Trip Medical Database, MEDLINE, EMBASE and communication with guideline developers until February 2018. Results: We identified 46 guidelines that used a shortened timeframe for their development. Nomenclature describing RGs varied across organisations, wherein the United States Centers for Disease Control and Prevention produced ‘Interim Guidelines’, the National Institute for Health and Care Excellence in the United Kingdom developed ‘Short Clinical Guidelines’, and WHO provided ‘Rapid Advice’. The rationale for RGs included response to emergencies, rapid increases in cases of a condition or disease severity, or new evidence regarding treatment. In general, the methods to assess the quality of evidence, the consensus process and the management of the conflict of interest were not always clear. While we identified another 11 RGs from other institutions, there was no reference to timeframe and reasons for conducting a RG. The three organisations mentioned above provide guidance for the development of RGs. Conclusions: There is a lack of standardised nomenclature and definitions regarding RGs and there is inconsistency in the methods described in manuals and in RG. It is therefore important that all RGs provide a detailed and transparent description of their methods in order for readers and end-users to be able to assess their quality and validate their findings.spa
dc.format.extent11spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherBMC (BioMed Central)spa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.titleDevelopment of rapid guidelines : 1. Systematic survey of current practices and methodsspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Investigación Clínica en Enfermedades del Niño y del Adolescente - Pediacienciasspa
dc.identifier.doi10.1186/s12961-018-0327-8-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
oaire.citationtitleHealth Research Policy and Systemsspa
oaire.citationstartpage1spa
oaire.citationendpage11spa
oaire.citationvolume16spa
oaire.citationissue61spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
dc.publisher.placeLondres, Inglaterraspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsGuideline-
dc.subject.decsGuía-
dc.subject.decsEmergencies-
dc.subject.decsUrgencias Médicas-
dc.subject.decsMethodology-
dc.subject.decsMetodología-
dc.subject.decsPractice Guideline-
dc.subject.decsGuía de Práctica Clínica-
dc.identifier.urlhttps://health-policy-systems.biomedcentral.com/articles/10.1186/s12961-018-0327-8spa
dc.description.researchgroupidCOL0058784spa
dc.relation.ispartofjournalabbrevHealth Res. Policy Syst.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
KowalskiSergio_2018_DevelopmentRapidGuidelines.pdfArtículo de investigación930.32 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons